Advertisement

Kona Medical, maker of fully non-invasive ultrasound-based renal ablation technologies, closes a $40 million Series C round, bringing its total for the year to $70 million.

Kona Medical logo

Hypertension treatment devices maker Kona Medical closed a Series C funding round totaling $40 million in support of its ultrasound-based renal ablation systems.

Unlike other renal ablation systems, Kona's Surround Sound device uses external ultrasound to non-invasively target the nerves leading to and from the kidney, according to a press release.

Advertisement
Advertisement